American women and doctors are, once again, experiencing whiplash as the court system has revoked and restored access to the most widely used abortion medication in the country — and is poised to strip it away once more — all in the span of a week and a half. Last Friday, the Fifth Circuit Court of Appeals issued a ruling in Louisiana v. FDA, prohibiting abortion providers from mailing mifepristone , the first drug taken as part of the typical two-step medication abortion protocol, to patients